Jiao Song

Jiao is a clinical development leader with proven track record in leading trials from Phase 0 to III. She has over 12 years of working experience in pharmaceutical industry across discovery and development. Currently, she is a director in early clinical science and operations, responsible for the development and execution of multiple infectious disease and vaccines trials, with various roles as global program lead and/or study responsible scientist. Previously, she was an innovation leader with Janssen Clinical Innovation (JCI), a team whose mission is to develop and deliver innovative solutions to trials to enhance operational efficiencies of clinical research. In this role, Jiao led the development of novel trial models and platforms/processes leveraging real world data and digital technologies to address the pressing needs of patients, as well as to improve patient engagement and recruitment. Prior to joining JCI, Jiao worked as an research scientist in Immunology Discovery Research at Janssen and later transitioned to the Discovery Sciences team, where she focused on personalized medicine programs in various therapeutic areas using proteomic and metabolic profiling approaches. Jiao obtained her PhD in Molecular Pharmacology and MS in Statistics from Purdue University, Indiana.